NCT00170833View on ClinicalTrials.gov

Safety, Tolerability and Efficacy of Everolimus With Lower Versus Higher Levels of Tacrolimus in de Novo Renal Transplant Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

November 30, 2003

Primary Completion Date

November 30, 2005

Conditions
Renal Transplantation
Interventions
DRUG

Everolimus

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY